Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Income from Continuing Operations: 2017-2020

Historic Income from Continuing Operations for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$82.1 million.

  • Cogent Biosciences' Income from Continuing Operations fell 594.78% to -$11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.1 million, marking a year-over-year decrease of 157.14%. This contributed to the annual value of -$82.1 million for FY2020, which is 157.14% down from last year.
  • Cogent Biosciences' Income from Continuing Operations amounted to -$82.1 million in FY2020, which was down 157.14% from -$31.9 million recorded in FY2019.
  • Over the past 5 years, Cogent Biosciences' Income from Continuing Operations peaked at -$25.8 million during FY2017, and registered a low of -$82.1 million during FY2020.
  • In the last 3 years, Cogent Biosciences' Income from Continuing Operations had a median value of -$34.9 million in 2018 and averaged -$49.6 million.
  • In the last 5 years, Cogent Biosciences' Income from Continuing Operations grew by 8.44% in 2019 and then plummeted by 157.14% in 2020.
  • Cogent Biosciences' Income from Continuing Operations (Yearly) stood at -$25.8 million in 2017, then crashed by 35.26% to -$34.9 million in 2018, then increased by 8.44% to -$31.9 million in 2019, then plummeted by 157.14% to -$82.1 million in 2020.